IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q4 FY21 results · Jan–Mar 2021
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹460.38 crore (up 4.3% from Q4 FY20) and net profit of ₹75.25 crore (down 16.6% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a standalone basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 460.38 | 441.46 | +4.3% | 513.01 | −10.3% |
| Other income | 6.21 | 5.35 | +16.1% | 7.81 | −20.5% |
| Total income | 466.59 | 446.81 | +4.4% | 520.82 | −10.4% |
| Profit before tax | 105.97 | 130.08 | −18.5% | 153.63 | −31.0% |
| Net profit for the period | 75.25 | 90.26 | −16.6% | 114.81 | −34.5% |
| EPS, basic (₹) | 12.76 | 31.74 | −59.8% | 19.54 | −34.7% |
| Net margin (%) | 16.3 | 20.4 | 22.4 |
Standalone
- Filed with BSE
- 05 Jun 2021, 19:12 IST
- Board meeting
- 04 Jun 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE